Mastek Reports Q4FY26 Revenue Growth of 3.6%, Maintains Stable EBITDA at 16.1%

2 min read     Updated on 25 Apr 2026, 02:36 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Mastek reported Q4FY26 revenue of INR938 crores, up 3.6% QoQ, with stable EBITDA margin of 16.1%. Full year FY26 revenue grew 7% to INR3,699 crores, while PAT increased 7.5% to INR404 crores. The 12-month order backlog reached $300.4 million, growing 13.5% YoY. AI-led deals comprised 9% of total business with 27 new AI programs added. The company generated INR542 crores operating cash and declared final dividend of INR16 per share. Margin guidance for FY27 remains at 16-16.1%.

powered bylight_fuzz_icon
38289240

*this image is generated using AI for illustrative purposes only.

Mastek delivered a stable performance in Q4FY26 with 3.6% quarter-on-quarter revenue growth, reaching INR938 crores, while maintaining operating EBITDA at 16.1%. The company reported dollar revenue of $103.5 million, up 1.4% sequentially. On a constant currency basis, revenue remained largely flat with marginal sequential growth of 0.3%. Despite salary increase impact of $1.1 million, the company sustained EBITDA margins through forex tailwind of 0.8% and execution of cost efficiencies.

Financial Performance Summary

Performance Metric Q4FY26 FY26 Full Year
Revenue (INR) INR938 crores INR3,699 crores
Revenue Growth (QoQ) 3.6% 7% YoY
Revenue (USD) $103.5 million $421.2 million
Operating EBITDA 16.1% 15.8%
PAT INR106 crores INR404 crores
Order Backlog (12-month) $300.4 million 13.5% YoY growth

The company closed FY26 with a 12-month backlog of $300.4 million, representing sequential growth of 1.5% and year-on-year growth of 13.5% in USD terms and 24.4% in INR terms. PAT for the quarter stood at INR106 crores, with a marginal sequential decline of 0.7% due to Labor Code true-up impact.

Order Book and Business Drivers

The order backlog demonstrated robust growth, increasing by 7.2% in INR terms and 1.6% in USD terms sequentially. AI-led deals continue to gain traction, comprising 9% of total deals. The company added more than 27 net new AI-focused customer programs during the quarter, spanning both AI for technology and AI for business-related initiatives.

Geographic performance showed resilience, with U.K. and AMEA regions growing sequentially in Q4, while the U.S. remained largely flat due to project right-shifting. The U.K. business maintained healthy EBITDA of nearly 20%. Healthcare and Life Sciences continues to show positive demand outlook, while Financial Services emerged as a strong performer during the quarter.

Operational Parameters and Cash Position

During the year, the company generated INR542 crores of operating cash, up 35% year-on-year. Cash and cash equivalents as of March 31, 2026, stood at INR938 crores, representing a 51% increase compared to March 2025. The company achieved its lowest Days Sales Outstanding (DSO) in the last 12 quarters at 73 days, supported by strong collections of $125 million during Q4.

Reflecting confidence in the business, Mastek declared a final dividend of INR16 per share, in addition to the interim dividend of INR8 per share declared during Q3. Total headcount stood at 4,730 with an addition of 54 employees during the quarter. Utilization rate improved to 80% in Q4, an increase of 3.3% from Q3.

Guidance and Outlook

Mastek has maintained its margin guidance of 16-16.1% for FY27, balancing operational efficiency improvements against pricing competitiveness and client budget reduction requests. The company expects FY27 to deliver better performance than the previous year, supported by strong order book momentum and positive demand indicators across key verticals including Healthcare, BFSI, and Retail.

The management emphasized that FY26 was a year of fundamental resets across geographies, particularly in North America where the team and focus have been restructured. As the company enters FY27, it anticipates positive growth driven by the execution of the 12-month order backlog and continued momentum in AI-led business transformation services.

Financial Guidance

Financial Guidance Target Range
Margin Guidance 16-16.1%
FY27 Growth Outlook Better than FY26

Historical Stock Returns for Mastek

1 Day5 Days1 Month6 Months1 Year5 Years
-2.63%+0.14%+22.96%-21.59%-23.28%+23.72%

How will Mastek's AI integration strategy impact its competitive positioning against larger IT services providers in the next 12-18 months?

What specific measures is the new North American leadership implementing to accelerate growth beyond the current two-quarter order book momentum?

Could the timing-related challenges in Healthcare and Life Sciences vertical signal broader industry headwinds that might affect future quarters?

Mastek Signs MOU to Sell Commercial Building for ₹60 Crore

1 min read     Updated on 24 Apr 2026, 08:24 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Mastek has signed a memorandum of understanding to sell a commercial building for ₹60 crore. The MOU represents the initial step in the asset divestment process, with the transaction subject to standard conditions. This strategic move allows the IT services company to optimize its asset portfolio while potentially providing additional liquidity for core business operations.

powered bylight_fuzz_icon
38588050

*this image is generated using AI for illustrative purposes only.

Mastek has entered into a memorandum of understanding (MOU) to sell a commercial building for ₹60 crore, the IT services company announced. This strategic asset divestment represents a significant transaction for the digital transformation specialist.

Transaction Overview

The MOU signing marks the initial step in the property sale process, with the commercial building valued at ₹60 crore. As a memorandum of understanding, this agreement establishes the framework for the potential sale, subject to the completion of standard due diligence and other customary conditions.

Transaction Details: Information
Asset Type: Commercial Building
Transaction Value: ₹60 Crore
Agreement Stage: MOU Signed
Transaction Type: Asset Sale

Strategic Implications

The decision to divest this commercial property aligns with corporate strategies focused on optimizing asset portfolios and capital allocation. For Mastek, this transaction could provide additional liquidity while allowing the company to focus resources on its core IT services and digital transformation business operations.

Next Steps

Following the MOU signing, the transaction will proceed through standard commercial real estate sale processes. The completion of the sale will depend on the fulfillment of various conditions and requirements typically associated with commercial property transactions of this scale.

Historical Stock Returns for Mastek

1 Day5 Days1 Month6 Months1 Year5 Years
-2.63%+0.14%+22.96%-21.59%-23.28%+23.72%

How will Mastek utilize the ₹60 crore proceeds from this asset sale to accelerate its digital transformation initiatives?

Does this property divestment signal a broader real estate portfolio optimization strategy across Mastek's operations?

What impact could this additional liquidity have on Mastek's acquisition plans or R&D investments in emerging technologies?

More News on Mastek

1 Year Returns:-23.28%